MEI Pharma (MEIP) Stock Forecast & Price Target

$3.06

-0.08 (-2.55%)

(As of 10:47 AM ET)

MEI Pharma - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 3 Analyst Ratings

Based on 3 Wall Street analysts who have issued ratings for MEI Pharma in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 3 have given a hold rating for MEIP.

Consensus Price Target

$7.00
128.76% Upside

High Forecast	$7.00
Average Forecast	$7.00
Low Forecast	$7.00

According to the 3 analysts' twelve-month price targets for MEI Pharma, the average price target is $7.00. The highest price target for MEIP is $7.00, while the lowest price target for MEIP is $7.00. The average price target represents a forecasted upside of 128.76% from the current price of $3.06.

Type	Current Forecast 8/23/23 to 8/22/24	1 Month Ago 7/24/23 to 7/23/24	3 Months Ago 5/25/23 to 5/24/24	1 Year Ago 8/23/22 to 8/23/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$7.00	$7.00	$7.00	$40.00
Forecasted Upside	128.76% Upside	102.31% Upside	102.31% Upside	515.45% Upside

Get MEI Pharma Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto 101 Media

This Crypto Is Set to Explode in August

With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Industry Giants are Investing Heavily in Blockchain Technology and THIS COIN is at the Heart of Their Strategy. It's a groundbreaking opportunity that could be poised for extraordinary gains.

Go here to get full details on this crypto now.

MEIP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MEIP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

MEI Pharma Stock vs. The Competition

Type	MEI Pharma	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.75	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	128.76% Upside	5,262.95% Upside	9.03% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/23/2024	Laidlaw 4 of 5 stars		Downgrade	Buy ➝ Hold
7/22/2024	Brookline Capital Management 3 of 5 stars	L. Cann Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/12/2024	Stifel Nicolaus 4 of 5 stars		Reiterated Rating	Hold ➝ Hold	$7.00	+102.31%
2/24/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral
2/13/2023	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy	$100.00 ➝ $40.00	+599.30%
2/8/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Underperform
12/6/2022	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
12/6/2022	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:16 AM ET.

MEIP Forecast - Frequently Asked Questions

What is MEI Pharma's forecast for 2024?: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for MEI Pharma is $7.00, with a high forecast of $7.00 and a low forecast of $7.00.
Should I buy or sell MEI Pharma stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MEI Pharma in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MEIP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MEIP, but not buy additional shares or sell existing shares.
Does MEI Pharma's stock price have much upside?: According to analysts, MEI Pharma's stock has a predicted upside of 102.31% based on their 12-month stock forecasts.
Has MEI Pharma been downgraded by Wall Street analysts recently?: Over the previous 90 days, MEI Pharma's stock had 2 downgrades by analysts.
What analysts cover MEI Pharma?: MEI Pharma has been rated by research analysts at Brookline Capital Management, and Laidlaw in the past 90 days.
Do Wall Street analysts like MEI Pharma more than its competitors?: Analysts like MEI Pharma less than other "medical" companies. The consensus rating for MEI Pharma is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MEIP compares to other companies.